Elderly Americans who volunteer for drug trials seldom make the cut. That makes it more difficult for researchers to know just how their new product will work for folks who often need it the most.
As we wait impatiently for a COVID-19 vaccine to free us from the current pandemic, a recent survey indicates surprising skepticism, and healthcare experts suggest we temper our expectations.
The concept of herd immunity is a growing part of the conversation about resolving the coronavirus pandemic. Infectious-disease researcher Daniel Altmann, PhD, offers insights on what it really means.